|
|
Viral/parasitic infections
|
|
|
Murine |
CD8+NK1.1+ |
Influenza infection |
10% of the lung CD8+T cells upregulate NK cell receptor NK1.1+ upon infection and offer protection |
Kambayashi et al. (11) |
|
|
Influenza infection |
Protection by Tc17 effector cells against influenza infection is IFN-γ dependent and accompanied by greater neutrophil influx into the lung |
Hamada et al. (23) |
|
|
LCMV infection |
CD8+NK1.1+ T cells escape TGF-beta control, resulting in delayed contraction and apoptosis and early pathogen response |
Ruiz et al. (54) |
|
|
Listeria infection |
CD8+NK1.1+ T cells offer protection by early antigen independent innate immune responses mediated by IFN-γ production and GzmB expression |
Seregin et al. (55) |
|
|
Malaria |
Increase in the liver cell numbers of CD8+NK1.1+ cells offer protection against liver stage Plasmodium yoelii infection |
Pied et al. (56) |
|
|
Malaria |
Significant increase in splenic antigen experienced, activated CD8+NK1.1+ T cells offer protection against acute Plasmodium chabaudi infection |
Muxel et al. (57) |
Human |
CD8+CD161+ |
Bacterial infections |
Enhanced migration and enrichment of IFN-γ secreting MAIT cells at the sites of infection helps clear the pathogen |
Le Bourhis et al. (19) |
|
|
EBV/CMV/influenza |
Self renewing, antigen specific CD8+CD161high memory cells express anti-apoptotic molecules and survive cytotoxic chemotherapy |
Turtle et al. (3) |
|
|
HCV/HBV |
Antigen specific CD8+CD161+ T cells secrete pro-inflammatory cytokines IFN-γ and TNF-α and offer protection |
Northfield et al. (4) |
|
|
Viral infection |
CD8+CD161+ T cells markedly enriched in the liver coexpressed IL-17 with high levels of IFN-γ and/or IL-22 and offer protection against viral infections. |
Billerbeck et al. (7) |
|
|
Tumor biology
|
|
|
Murine |
CD8+NK1.1+ |
Leukemia/lymphoma |
Expansion of cytolytic NKT cells producing IFN-γ limits GVHD in leukemia |
Baker et al., Verneris et al. (68, 69) |
|
|
Melanoma |
NKT like CD8+NK1.1+ T cells exert cytotoxicity against tumor cells and MDSCs, inhibit metastasis and improve survival |
Li et al. (34) |
|
|
Murine Pancreatic ductal Adenocarcinoma |
Adoptive transfer of antigen experienced CD8+NK1.1 cells offer anti-tumor protection |
Konduri et al. (53) |
|
|
Pancreatic Cancer |
Anti-tumor effects of NKT cells is dependent upon tumor associated macrophage mediated TH1 adaptive immune response |
Janakiram et al. (70) |
Human |
CD8+CD161+ |
Head and Neck cancer |
In HNSCC, immune evasion is mediated by down regulation of CD161 on Th17 cells in peripheral blood, primary tumor tissue, and lymph nodes |
Kesselring et al. (41) |
|
|
HPV-Oropharyngeal squamous cell cancer |
Antigen specific CD161+ T cells produce IL-17 and IFN-γ in the type-1 oriented tumor microenvironment resulting in reduced tumor burden and improved overall survival |
Welters et al. (75) |
|
|
Hepatocellular Carcinoma |
Co-expression of CD161 and IL-7R helps maintain proliferation of CD8+PD-1+ T cells partly through enhanced expression of IL-2, TNF-α, and perforin resulting in better prognosis |
Li et al. (76) |
|
|
Lymphoma |
In transplant setting, host NKT cells prevented lethal GVHD while perforin producing CD8+ T cells offered graft antitumor activity |
Pillai et al. (77) |
|
|
Lymphoma |
IL21 promoted expansion of Th1 skewed cytotoxic CAR NKT cells offering protection |
Ngai et al. (78) |
|
|
Multiple tumors |
KLRB1, the gene encodign CD161 is associated with favorable outcomes against multiple tumor models |
Gentles et al., Braud et al. (72, 73) |
|
|
Multiple tumors |
The potential immunoregulatory role of CD4+ CD161+ cells is mediated through soluble factors, high IL-10, IL-4, and TGF-β resulting in disease progression |
Iliopoulou et al. (79) |
|
|
NSCLC |
Tumor infiltrating CD8+CD161+ interact with LLT1 expressing germinal center B cells within TME resulting in improved survival |
Braud et al. (73) |
|
|
Pediatric Leukemia |
iNKT cell subsets in hHSCT recipients contribute to the maintenance of the remission state, possibly through the provision of antitumor cytokine IFN-γ. |
de Lalla et al. (80) |
|
|
Autoimmunity
|
|
|
Human |
CD8+CD161+ |
Autoimmune diseases |
IL-17 producing Th17 cells mediate tissue inflammation and autoimmune progression in gut, joints, and brain by secreting inflammatory cytokines like IL-23 |
Cosmi et al., Kleinschek et al., Lock et al., Tzartos et al., Annibali et al. (60–64) |
|
|
Systemic Lupus Erythematosus |
Abnormalities in the frequencies and levels of CD161 expression on CD8+ T cells and NKT cells correlate to the pathogenesis of SLE. |
Park et al. (67) |